We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Amgen and Illumina Enter Agreement

News   Jan 20, 2014

 
Amgen and Illumina Enter Agreement
 
 
 

RELATED ARTICLES

Personalized Immunotherapy Refined by Mass Spec-Machine Learning Pairing

News

A combination of mass spectrometry and a novel computational tool is more accurately identifying the molecular signs of cancer likely to be presented to helper T cells, which stimulate and orchestrate the immune response to tumors and infectious agents.

READ MORE

New Drug Combo Could Work Against Broader Array of Cancer Cells

News

Researchers have discovered two drugs that work together to disrupt cancer cells’ ability to survive.

READ MORE

DNA Fracturing Causes Rewiring of Genes in Cancer

News

A new study has brought attention to genomic structural variation as a previously unappreciated mechanism involved in altering DNA methylation, a form of gene control, in human cancers.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE